Elon Musk’s Neuralink vs. Bill Gates and Jeff Bezos’ dubbing:…

Elon Musk’s Neuralink vs. Bill Gates and Jeff Bezos’ dubbing:…

Facebook
Twitter
LinkedIn

Often referred to as the most advanced computer in existence, the human brain is responsible for regulating our bodies, storing vast amounts of information and processing it almost instantly. As such an essential part of our existence, brain damage can lead to life-altering consequences.

In an effort to understand the brain’s complexity and replicate its capabilities, some of the wealthiest individuals invest billions of dollars to advance modern technologies. One such example is Tesla Inc. CEO Elon Muskwho started neurolink in 2016 with a $100 million investment. Neuralink’s focus is on developing brain-computer interfaces, and in 2021 the company unveiled a monkey that plays pong, controlling the game with just its brain. Despite numerous controversial claims about Neuralink’s potential applications, the company has been investigated and investigated for allegations ranging from handling dangerous pathogens to animal deaths.

To keep up to date with top startup news and investments, Sign up for Benzinga’s Startup Investing & Equity Crowdfunding Newsletter

Neuralink recently raised $205 million in a Series C funding round with participation from alphabet inc‘s Google Ventures, Robert Belson, Founder of ARCH Venture Partners, OpenAI CEO Sam Altman, and other influential investors. Musk isn’t alone in investing significant resources in brain research, however. microsoft inc co-founder Bill Gates And amazon inc Founder Jeff Bezos has also invested Synchronous, a startup focused on decoding the brain’s neural code. Synchron raised $75 million in its Series C round, including investments from gates limit, Bezos Expeditions, ARCH Venture Partners, Alumni Ventures and numerous other venture capital funds. The funds raised will help accelerate the development of Synchron’s first platform product, the Synchron Switch, a brain-computer interface (BCI).

Synchron’s website boasts 105 patents and claims “an endovascular…

[ad_2]

Source story

More to explorer